Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Mai 2022 08:00 ET | Quelle: UroMems

UroMems Appoints Steffen Hovard to Chairman of the Board of Directors

GRENOBLE, France, May 11, 2022 (GLOBE NEWSWIRE) -- UroMems, developer and manufacturer of UroActive™, the first active medical implantable device for treating stress urinary incontinence, today...
06. April 2021 08:00 ET | Quelle: UroMems

UroMems Completes €23 Million Series B Financing

Further participation from existing investors raised additional €7 million Additional capital to fund initiation of the first clinical trial of eAUS in patients suffering from stress urinary...
20. Mai 2020 08:00 ET | Quelle: UroMems

UroMems Raises €16 Million to Advance Development of Electronic Artificial Urinary Sphincter (eAUS) for Stress Urinary Incontinence

Capital will fund completion of preclinical studies and initiation of the first clinical trial in patients suffering from stress urinary incontinence caused by sphincter insufficiency Dr. Friedrich...
27. April 2020 08:00 ET | Quelle: UroMems

UroMems Appoints Medical Device Industry Leader Steffen Hovard to Board of Directors

GRENOBLE, France, April 27, 2020 (GLOBE NEWSWIRE) -- UroMems, developer and manufacturer of its first product, the electronic artificial urinary sphincter (eAUS), for the treatment of stress urinary...
25. Oktober 2019 07:00 ET | Quelle: UroMems

UroMems Wins Prestigious Prix Galien Med’Start-Up for Best Collaboration in the Medtech or Digital Sector

NEW YORK, Oct. 25, 2019 (GLOBE NEWSWIRE) -- UroMems, developer of the eAUS electronic artificial urinary sphincter, today announced that it has received the 2019 Prix Galien USA Med’Start-Up Award...